
Sensus Healthcare, Inc.: shareholders and insiders
Price
$2.27
November 18, 2026Market cap $37M
What Ploutos Investor adds for Sensus Healthcare
Part of Ploutos Investor, €9.99 a month
- The full history: 11 fiscal years, from 2015
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Insiders and their shares
Purchases and sales by officers and directors from Nov 18, 2025 to Nov 17, 2026, from their own Form 4 filings.
Bought on the market
$780.3K
3 people
Sold on the market
–
nobody
From Nov 18, 2025 to Nov 18, 2026, the days the chart shows. Change its range and the figures follow.
How the sales were made, as a share of their value
No sales in the period.
By year
Insiders' open-market purchases (up) and sales (down), by value, since Nov 18, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.
2026·bought $648.2K by 2 people·no sales
- 2025: bought $132.1K by 3 people, no sales
- 2026: bought $648.2K by 2 people, no sales
- Nov 16, 2026Joseph C SardanoCHIEF EXECUTIVE OFFICERKind
- Aug 31, 2026Eric SachettaDirectorKind
- Aug 28, 2026Eric SachettaDirectorKind
- Aug 27, 2026Eric SachettaDirectorKind
- Aug 26, 2026Eric SachettaDirectorKind
- Aug 24, 2026Eric SachettaDirectorKind
- Aug 21, 2026Eric SachettaDirectorKind
- Aug 20, 2026Joseph C SardanoCHIEF EXECUTIVE OFFICERKind
- Aug 20, 2026Eric SachettaDirectorKind
- May 12, 2026Eric SachettaKind
- Feb 24, 2026Eric SachettaKind
| Date | Person | Kind | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 16, 2026 | Joseph C SardanoCHIEF EXECUTIVE OFFICER | 30.0K | $2.40 | $72.1K | Form 4 | |
| Aug 31, 2026 | Eric SachettaDirector | 27.3K | $3.54 | $96.6K | Form 4 | |
| Aug 28, 2026 | Eric SachettaDirector | 37.5K | $3.44 | $129.0K | Form 4 | |
| Aug 27, 2026 | Eric SachettaDirector | 10.9K | $3.18 | $34.8K | Form 4 | |
| Aug 26, 2026 | Eric SachettaDirector | 9,708 | $3.29 | $31.9K | Form 4 | |
| Aug 24, 2026 | Eric SachettaDirector | 34.7K | $3.25 | $112.9K | Form 4 | |
| Aug 21, 2026 | Eric SachettaDirector | 7,000 | $3.25 | $22.8K | Form 4 | |
| Aug 20, 2026 | Joseph C SardanoCHIEF EXECUTIVE OFFICER | 20.0K | $3.02 | $60.5K | Form 4 | |
| Aug 20, 2026 | Eric SachettaDirector | 24.0K | $3.13 | $75.1K | Form 4 | |
| May 12, 2026 | Eric Sachetta | 1,500 | $3.34 | $5.0K | Form 4 | |
| Feb 24, 2026 | Eric Sachetta | 2,000 | $3.81 | $7.6K | Form 4 |
From the Form 4s insiders file with the SEC within two business days of each trade. Before Aug 24, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.
Insiders and their shares
Every buy and sale by SRTS's officers and directors from 2016 up to November 17, 2025, 10 more calendar years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 3 years.
and 5 more, back to 2016
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Renaissance TechnologiesIn the quarter-5.2%
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Renaissance Technologies | 229.6K | -5.2% | $700.0K | 0.00% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 1.40% of its shares outstanding were held short, +1.0% since the report before.
- Shares held short
- 229.9K
- 1.40%
- Since the report before227.6K on Sep 30, 2026
- +1.0%
- 14.3
- 16.0K
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 54.7K
- Nov 15, 2023: Shares held short 53.3K
- Nov 30, 2023: Shares held short 67.4K
- Dec 15, 2023: Shares held short 24.9K
- Dec 29, 2023: Shares held short 34.4K
- Jan 12, 2024: Shares held short 39.2K
- Jan 31, 2024: Shares held short 37.7K
- Feb 15, 2024: Shares held short 49.4K
- Feb 29, 2024: Shares held short 24.7K
- Mar 15, 2024: Shares held short 65.8K
- Mar 28, 2024: Shares held short 33.4K
- Apr 15, 2024: Shares held short 33.4K
- Apr 30, 2024: Shares held short 31.0K
- May 15, 2024: Shares held short 437.4K
- May 31, 2024: Shares held short 394.2K
- Jun 14, 2024: Shares held short 390.4K
- Jun 28, 2024: Shares held short 410.5K
- Jul 15, 2024: Shares held short 439.8K
- Jul 31, 2024: Shares held short 449.6K
- Aug 15, 2024: Shares held short 469.3K
- Aug 30, 2024: Shares held short 465.6K
- Sep 13, 2024: Shares held short 491.5K
- Sep 30, 2024: Shares held short 532.2K
- Oct 15, 2024: Shares held short 585.8K
- Oct 31, 2024: Shares held short 535.6K
- Nov 15, 2024: Shares held short 593.7K
- Nov 29, 2024: Shares held short 486.1K
- Dec 13, 2024: Shares held short 583.5K
- Dec 31, 2024: Shares held short 1.21M
- Jan 15, 2025: Shares held short 1.36M
- Jan 31, 2025: Shares held short 1.55M
- Feb 14, 2025: Shares held short 1.18M
- Feb 28, 2025: Shares held short 845.6K
- Mar 14, 2025: Shares held short 858.1K
- Mar 31, 2025: Shares held short 837.6K
- Apr 15, 2025: Shares held short 874.7K
- Apr 30, 2025: Shares held short 806.7K
- May 15, 2025: Shares held short 908.5K
- May 30, 2025: Shares held short 898.6K
- Jun 13, 2025: Shares held short 834.8K
- Jun 30, 2025: Shares held short 854.6K
- Jul 15, 2025: Shares held short 807.0K
- Jul 31, 2025: Shares held short 824.7K
- Aug 15, 2025: Shares held short 910.5K
- Aug 29, 2025: Shares held short 826.2K
- Sep 15, 2025: Shares held short 760.2K
- Sep 30, 2025: Shares held short 751.8K
- Oct 15, 2025: Shares held short 709.0K
- Oct 31, 2025: Shares held short 588.4K
- Nov 14, 2025: Shares held short 570.4K
- Nov 28, 2025: Shares held short 535.8K
- Dec 15, 2025: Shares held short 517.1K
- Dec 31, 2025: Shares held short 484.8K
- Jan 15, 2026: Shares held short 491.8K
- Jan 30, 2026: Shares held short 579.4K
- Feb 13, 2026: Shares held short 514.4K
- Feb 27, 2026: Shares held short 483.7K
- Mar 13, 2026: Shares held short 395.0K
- Mar 31, 2026: Shares held short 368.1K
- Apr 15, 2026: Shares held short 422.0K
- Apr 30, 2026: Shares held short 309.3K
- May 15, 2026: Shares held short 204.2K
- May 29, 2026: Shares held short 200.1K
- Jun 15, 2026: Shares held short 193.0K
- Jun 30, 2026: Shares held short 200.8K
- Jul 15, 2026: Shares held short 202.1K
- Jul 31, 2026: Shares held short 205.9K
- Aug 14, 2026: Shares held short 209.2K
- Aug 31, 2026: Shares held short 216.2K
- Sep 15, 2026: Shares held short 227.2K
- Sep 30, 2026: Shares held short 227.6K
- Oct 15, 2026: Shares held short 229.9K
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading60.7% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 60.7% of the shares in the reported trades were short sales, against 37.8% in the 14 before.
- Last 14 sessionsOct 29, 2026 – Nov 17, 2026
- 60.7%
- The 14 beforeOct 9, 2026 – Oct 28, 2026
- 37.8%
- Change
- +22.9 pts
- Short sales a dayon average, of 408.2K shares
- 247.7K
- More than atof 3,666 US-listed companies, same days
- 84%
- Median of alleight in ten from 34.6% to 63.7%
- 50.3%
- Short sales
- Oct 9, 2026: Short sales 32.4%
- Oct 12, 2026: Short sales 23.3%
- Oct 13, 2026: Short sales 88.8%
- Oct 14, 2026: Short sales 22.1%
- Oct 15, 2026: Short sales 48.1%
- Oct 16, 2026: Short sales 37.1%
- Oct 19, 2026: Short sales 32.3%
- Oct 20, 2026: Short sales 12.7%
- Oct 21, 2026: Short sales 27.4%
- Oct 22, 2026: Short sales 11%
- Oct 23, 2026: Short sales 91.9%
- Oct 26, 2026: Short sales 35.7%
- Oct 27, 2026: Short sales 25.5%
- Oct 28, 2026: Short sales 13.6%
- Oct 29, 2026: Short sales 30.7%
- Oct 30, 2026: Short sales 63.4%
- Nov 2, 2026: Short sales 11.6%
- Nov 3, 2026: Short sales 65.2%
- Nov 4, 2026: Short sales 36.5%
- Nov 5, 2026: Short sales 18%
- Nov 6, 2026: Short sales 17.6%
- Nov 9, 2026: Short sales 38.7%
- Nov 10, 2026: Short sales 41%
- Nov 11, 2026: Short sales 31%
- Nov 12, 2026: Short sales 37.3%
- Nov 13, 2026: Short sales 34.9%
- Nov 16, 2026: Short sales 60%
- Nov 17, 2026: Short sales 51.2%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
What the insiders hold
The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.
- Joseph C SardanoCHIEF EXECUTIVE OFFICERDirectly1.25M
- Eric SachettaDirectorDirectly294.8K
- Michael SardanoPRESIDENT AND GENERAL COUNSELDirectly118.8K
- John HeinrichDirectorDirectly59.9K
- Javier RampollaCHIEF FINANCIAL OFFICERDirectly40.7K
| Person | Directly | Indirectly | After the trade of | Filing |
|---|---|---|---|---|
| Joseph C SardanoCHIEF EXECUTIVE OFFICER | 1.25M | – | Nov 16, 2026 | Form 4 |
| Eric SachettaDirector | 294.8K | – | Aug 31, 2026 | Form 4 |
| Michael SardanoPRESIDENT AND GENERAL COUNSEL | 118.8K | 766 | Nov 18, 2025 | Form 4 |
| John HeinrichDirector | 59.9K | – | May 20, 2024 | Form 4 |
| Javier RampollaCHIEF FINANCIAL OFFICER | 40.7K | – | Feb 10, 2025 | Form 4 |
A lower bound: it counts only the 5 officers and directors with a market trade since Nov 19, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.
The ETFs that hold it
Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- IWCiShares Micro-Cap ETFWeight in the fund0.01%
- DFSVDimensional US Small Cap Value ETFWeight in the fund0.00%
- DFASDimensional U.S. Small Cap ETFWeight in the fund0.00%
- VXFVanguard Extended Market Index FundWeight in the fund0.00%
- VTIVanguard Total Stock Market Index FundWeight in the fund0.00%
- DFACDimensional U.S. Core Equity 2 ETFWeight in the fund0.00%
6 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 42
- Q4 2025: Managers 45
- Q1 2026: Managers 42
- Q2 2026: Managers 38
Institutional investors by quarter
The fund managers holding SRTS, quarter by quarter, from Q3 2016 to Q2 2025, 36 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 38 managers held 3.65M shares, worth $11M. During the quarter 4 opened a position, 8 closed one, 7 added and 12 trimmed.
The largest holders, Q2 2026
- Pacific Ridge Capital PartnersIn the quarter-0.8%
- Vanguard Capital ManagementIn the quarter+1.9%
- Dimensional Fund AdvisorsIn the quarter-18%
- Divisadero Street Capital ManagementIn the quarter-2.7%
- Renaissance TechnologiesIn the quarter-3.9%
- Geode Capital ManagementIn the quarter-6.9%
- UBS GroupIn the quarter-12%
- SachettaIn the quarter+1.0%
- Greenline Wealth ManagementIn the quarter
- North Star Investment ManagementIn the quarter
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| Pacific Ridge Capital Partners | 789.7K | -0.8% | $2.4M |
| Vanguard Capital Management | 660.4K | +1.9% | $2.0M |
| Dimensional Fund Advisors | 316.1K | -18% | $954.8K |
| Divisadero Street Capital Management | 278.5K | -2.7% | $841.0K |
| Renaissance Technologies | 242.3K | -3.9% | $731.8K |
| Geode Capital Management | 154.2K | -6.9% | $465.7K |
| UBS Group | 152.6K | -12% | $460.8K |
| Sachetta | 152.0K | +1.0% | $459.1K |
| Greenline Wealth Management | 128.8K | $388.9K | |
| North Star Investment Management | 125.6K | $379.3K |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
The full analysis
What do Sensus Healthcare's filings show?
Who buys and sells is one part of Sensus Healthcare's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Have SRTS's insiders bought or sold?
From Aug 24, 2026 to Nov 17, 2026 Sensus Healthcare's insiders bought $635.6K and sold 0 of shares on the market. – of the sales were under set 10b5-1 plans.
Which well-known managers hold SRTS?
1 of the managers we track held the shares on Sep 30, 2026. The largest position was Renaissance Technologies's, worth $700.0K.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.